- Conditions
- Coronary Artery Disease, Atherosclerosis
- Interventions
- ACP-501
- Drug
- Lead sponsor
- MedImmune LLC
- Industry
- Eligibility
- 30 Years to 85 Years
- Enrollment
- 16 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
Source: ClinicalTrials.gov public record
Updated Mar 13, 2019 · Synced May 22, 2026, 2:43 AM EDT